And so, the middle of the week has arrived. However, we are breaking from our usual routine so that we can speak at the Healthcare Supply Chain Association forum later today (
see this). As a result, a colleague may be enlisted to fill in for us over the next 36 hours. Nonetheless, we do have a few items for you this morning and hope that you will excuse any disruption. After all, meeting a few people now and then is a necessary part of the job. Meanwhile, here are some tidbits to get you started. Have a grand day and see you soon...
Biogen To Pay Elan $3.25B For Full Tysabri Rights (Bloomberg News)
Merck Hit With $285K Verdict In Fosamax Trial (Reuters)
Massachusetts Cites Violations at 32 Compounding Pharmacies (Reuters)
Allergan Plans To Sell Lap-Band And Obesity Biz By June (Bloomberg News)
Merck KGgA Signs $225M Personlized MS Drug Deal (Pharma Times)
ACE Inhibitors Linked To Hallucinations In Elderly (MedPage Today)
microphone pic thx to laineema on flickr